Sanofi announced limited details about the alliance June 26 at the American Diabetes Association 78th Scientific Sessions in Orlando, Fla. Together, the three companies plan to create and commercialize a new generation of “all-in-one” pre-filled insulin patch pumps for patients with Type 2 diabetes.
The collaboration combines Sanofi’s experience developing diabetes solutions, Sensile Medical’s work developing micro-pump technologies and digital health expertise from Verily, formerly called Google Life Sciences.
More articles on health IT:
Microsoft adds VP, chief architect to healthcare team
5 things to know about Mercy’s IT consulting arm, Mercy Technology Services
David Geller spent 20 years working with DreamWorks, Yahoo — Here’s why he pivoted to healthcare
